VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Promising agents under investigation in polycythemia vera

Lucia Masarova, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses some promising agents in development for the treatment of polycythemia vera (PV), including KRT-232, givinostat, and LSD inhibitors. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter